Since 30S ribosomes are modified in bacteria resistant to streptomycin,l, 2 the drug probably affects and kills sensitive cells through an interaction with ribosomes.3 Studies based on current understanding of the ribosome cycle in protein synthesis have enabled us to show that streptomycin blocks this cycle at a specific point. The block can account for the drug's bactericidal effect.
A typical example of the changes is seen in Figure 1 (solid lines), which shows characteristic analyses of cell extracts made just before addition of streptomycin, and 2 and 40 minutes thereafter. At the moment of addition of streptomycin, ribosomes were found as free 30S and 50S particles, as well as bound to mRNA. The successive faster-moving peaks correspond to mRNA molecules bearing one, two, three, etc., ribosome couples. After addition of the drug, protein synthesis was rapidly inhibited (more than 90% within 10 min), and the following changes in ribosome distribution occurred: (1) a decrease in large polyribosomes and in free 30S and 508 particles; and (2) a striking accumulation of 708 mnotionomrs (i.e., single ribosome couples).
Pulse-labeled H3-RNA (Fig. 1 , dotted lines) continued to be associated with the remaining polyribosomes and 70S monomers. However, the ratio of H3/ C 14 in 70S monomers compared to that in larger polyribosomes gradually declines (Fig. 1) obtained at later times.
M I N U T E S
tracted from E. coli and then added to preincubated extracts from sensitive cells was equally sensitive to streptomycin. Thus, in extracts prepared from a streptomycin-sensitive strain, as in whole cells, protein synthesis directed by natural mRNA can be completely abolished by streptomycin.
(c) Streptomycin blocks normal initiation of protein synthesis: Why does streptomycin block protein synthesis directed by natural mRNA, but not that directed by the artificial mRNA's such as poly U, poly A, and poly C? The most critical difference between the two kinds of RNA is known to be that natural mRNA initiates protein synthesis by a mechanism requiring the apposition of fmet-tRNA to the corresponding AUG codon.'7 In contrast, poly U initiates protein synthesis by a mechanism that seems to require distortion of a ribosomal binding site such as occurs in the presence of elevated concentrations of Mg2+. 8, 23 These considerations, independent of the accumulation of 70S monomers observed in intact cells (section (a)), also suggest that streptomycin inhibits the normal initiation of protein synthesis.
If streptomycin selectively inhibits natural (fmet-tRNA-dependent) initiation of protein synthesis, then (1) initiation that is not natural might not be blocked; (2) protein synthesis directed by mRNA already functioning on ribosomes should be relatively uninhibited; and (3) the initiation process should be specifically blocked by streptomycin, presumably before the formation of the first peptide bond.
The following observations show that all these expectations have been fulfilled. (1) At high levels of Mg2 +, initiation with natural mRNA can occur by an abnormal mechanism.8 23 Streptomycin is still bound, for its activity in promoting miscoding is increased at high concentrations of Mg2 +;24 nevertheless, protein synthesis directed by phage RNA (Fig. 3) , as well as by the endogenous mRNA made in cell extracts,17 escapes the inhibitory action of the drug. Streptomycin inhibition of the protein synthesis directed by phage RNA decreased from 93 to 37 per cent as the Mg2+ concentration was raised from 5 AUG, which contains the natural initiating codon AUG. Protein synthesis carried out at 7 mM Mg2+ or less is completely inhibited by streptomycin, but streptomycin has no inhibitory effect at 20 mM Mg2+ (Fig. 4) , where the variant mechanism of initiation is possible.
(2) The completion of polypeptides by endogenous mRNA already on ribosomes in a DNase-treated extract17 is very insensitive to streptomycin (Fig.  2 (samples with no added R17 RNA) and unpublished results).
(3) R17 RNA directs the binding to ribosomes of fmet-tRNA and of alatRNA, which correspond to the first and second amino acids incorporated into protein. The amount of tRNA bound in the presence and in the absence of streptomycin was estimated in sucrose gradients. The effect of the drug was unequivocal: streptomycin sharply reduced the amount of 83-fmet-tRNA and H3-ala-tRNA bound to ribosomes (to 15% and 0-6% of the control, respectively; Table I ). In a corroborative experiment, protein synthesis was directed by R17 RNA, and the formation of the dipeptide fmet-ala was gauged by the technique of Ghosh and Khorana.12 The amount of fmet-ala formed in the presence of streptomycin was less than one tenth the amount formed and incorporated into acid-insoluble protein chains in the absence of the drug.
Discussion. (0--O) no streptomycin; (0-) with 2 p&g/mi streptomycin.
In the inset, the inhibitory effect of streptomycin is plotted as a function of Mg' + concentration. (0-C) no streptomycin; (0-_) with 2 pug/ml streptomycin.
Inset as in Fig. 3. VOL. 60, 1968 877 going experiments, we suggest that streptomycin alters the normal interaction of sensitive 30S and 50S ribosomes on mRNA,25 and that this leads to the appearance of "streptomycin monomers," i.e., ribosomes blocked as aberrant initiation complexes. The modified complexes cannot form peptide bonds, and their movement along the messenger is impeded. Hence the addition of further ribosomes is inhibited and the normal cycle of ribosome function is interrupted. Though the modified initiation complex does not form protein, streptomycin does not prevent the completion of growing peptide chains. Therefore, as more and more ribosomes bind streptomycin in the cell during the initiation process, polyribosomes gradually decrease in size until there tends to be only a pseudoinitiation complex (70S monomer) on each mRNA chain.
According to this view, the mutation to a streptomycin-resistant form alters the way in which 30S ribosomes interact with 50S ribosomes, so that functional initiation complexes can be formed even in the presence of the drug. Indeed, Leon and Brock27 have shown that the mutation has a direct effect on the interaction of the subunits; in the absence of the drug, 70S ribosomes from sensitive strains showed a greater tendency to hold together at high temperature than did ribosomes from a resistant mutant.
Our present understanding of the ribosome cycle (see introduction) suggests that 70S monomers might accumulate with inhibition of protein synthesis either by the stabilization of 30S-50S couples in a completely abnormal way, or by the blockage of newly formed monomers at protein initiation, or by the blockage of dissociation of the monomers at the termination of a polypeptide chain. Although 3 Asg/ml to the preincubated extract before other additives. After incubation at 360, the samples were centrifuged through 15-30% sucrose gradients in 0.04 M KC1, 0.01 M tris(hydroxymethyl) aminomethane (Tris)-HCl, pH 7.0, and 0.01 M magnesium acetate for 4 hr at 24,000 rpm in the SB-110 rotor of the International B-60 ultracentrifuge. Each gradient was run through a Gilford model 2000 absorbance recorder to locate the peak of 70S ribosomes and was then collected in 15 fractions. The fractions were precipitated with ice-cold 5% trichloroacetic acid, plated on glass fiber filters, and counted in a Packard liquid scintillation spectrometer. The counts bound to ribosomes in each gradient are tabulated. The sources of label were, in Experiment 1, 18,000 cpm S35-fmet-tRNA and 6,600 cpm H-ala-tRNA (180 ;&g total tRNA) and, in Experiment 2, 26,000 cpm S8"-fmet-tRNA and 40,000 cpm H3-ala-tRNA (340 yg total tRNA). In both experiments, of the radioactivity remaining insoluble in cold acid after the gradient centrifugation, about 40% of the S85 and 80% of the HI were bound to ribosomes in the complete system; the remainder were in the soluble phase. In Experiment 2, to gauge tRNA binding in the absence of measurable protein synthesis, the Mg2+ concentration was reduced from the standard 11 the detailed mechanism of the accumulation of 70S monomers in intact cells is not analyzed here, these monomers appear to be modified initiation complexes. Among the less likely alternatives are the following: (1) It seems unlikely that streptomycin acts as a bifunctional ligand to "glue" together free 30S and 50S particles to form 70S monomers, because streptomycin itself does not cause these particles to associate in extracts.26 (2) The 70S monomers do not result from their failure to leave mRNA on completion of a polypeptide chain, for if initiation were not blocked, one would observe an accumulation of large polyribosomes rather than of 70S monomers. (3) It is also unlikely that the 70S monomers represent 30S-50S couples that did not dissociate after polypeptide chain termination and moved undissociated to a new mRNA. If this were the case, streptomycin would not block the initiation of protein synthesis on free 30S and 50S particles. However, initiation of protein synthesis directed by R17 RNA, a process that begins on the free 30S and 50S ribosomes in extracts,10 is totally blocked by the drug (Fig. 2) .
The nature of the blocked initiation complexes is not completely known. In particular, it is not yet clear whether they contain any tRNA, since streptomycin reduces the amount of S35-fmet-tRNA bound in the presence of phage RNA (Table 1) . However, 30S-50S couple formation ordinarily requires tRNA,8 and it may be that fmet-tRNA is bound in a deacylated form, or is deacylated on the abortive complex, releasing the S35-label from the ribosomes. (See Note added in proof.) (b) A note on killing by streptomycin: What is the relationship between the effect of streptomycin on the initiation of a protein chain and its well-known effects occurring during the synthesis of a protein chain, manifested either as inhibition20-22 or miscoding22, 24, 28 in the translation of certain codons? Since at bactericidal concentrations of 10 pg/ml or higher streptomycin blocks ribosomes at initiation, no protein synthesis then takes place. The interaction of streptomycin with ribosomes located at later codons is then precluded. In other words, neither misreading nor other effects at internal codons seem relevant to the killing action of the drug. 29 While the accumulation of aberrant 70S monomers with consequent interruption of protein synthesis is sufficient to explain the arrest of cell growth, we have no definitive evidence as yet that it represents the primary event in the bactericidal action of streptomycin. However, one simple possibility is that streptomycin binds to ribosomes so tightly that the formation of the aberrant initiation complex is irreversible in sensitive cells and leads to cell death. Summary.-When lethal concentrations of streptomycin are added to a growing culture, polyribosomes gradually decrease in size and number, and 70S monomers accumulate progressively (to as much as 60% of the total ribosomes by 40 min). The monomers do not incorporate radioactive amino acids into protein. These monomers are probably at the beginning of the mRNA molecules, a suggestion substantiated by the action of streptomycin in cell extracts. One molecule of drug per ribosome completely blocks R17 phage RNAdirected protein synthesis in extracts of a sensitive strain, but not of a resistant strain, at iVg2+ concentrations of 7-10 mM where initiation is "natural" (fmettRNA-dependent). On the other hand, polypeptide chain elongation can con-VOL. 60, 1968 
